“…Several lung organoid models, derived from primary cells or induced pluripotent stem cells (iPSCs), have been developed to study the proximal airways and distal alveoli (Barkauskas et al, 2013(Barkauskas et al, , 2017Dye et al, 2015;Ekanger et al, 2022;Frum et al, 2023;Gotoh et al, 2014;Hein et al, 2022;Miller et al, 2018Miller et al, , 2019Miller et al, , 2020Rock et al, 2009). Recently, iPSC-derived alveolar type II (AT2) organoids have emerged as a powerful tool to study alveolar homeostasis and disease such as SARS-CoV-2 (Huang et al, 2020;Hurley et al, 2020;Jacob et al, 2017;Mirabelli et al, 2021).…”